Fig. 3
From: The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell
Effect of Isoliquiritigenin on ROS production. a Flow cytometry analysis of reactive oxygen species in ISL (10 μM) treated or untreated HASMCs for 48 h. DCFDA was used for intracellular ROS labeling. The ROS levels were calculated as a ratio of relative to untreated HASMCs. b Total SOD enzyme activity in cells were determined by SOD activity test. All values represented as mean ± SD, n = 5, *: P < 0.05 compared with untreated HASMCs. Arrows indicated autofluorescence